Pyrroloquinoline Quinone Protects Against Light-Induced Retinal Damage in Association with the Suppression of c-Fos...

Area of Science:

• Ophthalmology
• Neuroscience
• Pharmacology

Background:

• Age-related macular degeneration (AMD) is a leading cause of vision loss, characterized by oxidative stress and inflammation.
• Pyrroloquinoline quinone (PQQ) is known for its neuroprotective properties, but its efficacy in AMD models is not well-established.

Purpose of the Study:

• To investigate the protective effects of PQQ against retinal damage in cellular and animal models relevant to AMD.
• To explore the underlying mechanisms of PQQ's action in mitigating phototoxic injury.

Main Methods:

• ARPE-19 cells were treated with PQQ and exposed to all-trans-retinal (ATR) to assess cytotoxicity.
• Rats were treated with PQQ and exposed to high-intensity light to induce photoreceptor degeneration.
• Retinal function was evaluated using electroretinography, and retinal morphology was assessed via haematoxylin-eosin staining.
• Western blot analysis was used to examine the expression of c-Fos.

Main Results:

• PQQ dose-dependently reduced ATR-induced cytotoxicity in ARPE-19 cells.
• PQQ treatment in rats significantly preserved retinal function and outer nuclear layer morphology after light exposure.
• PQQ administration suppressed the upregulation of c-Fos, a marker of cellular stress, in a dose-dependent manner.

Conclusions:

• PQQ exhibits significant protective effects against phototoxic damage in both cellular and in vivo models of AMD.
• The findings suggest that PQQ's therapeutic benefits in AMD may be mediated through the suppression of c-Fos signaling.
• PQQ warrants further investigation as a potential therapeutic agent for age-related macular degeneration.